SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Innodata, Inc. is a data engineering company, which engages in providing artificial intelligence software platforms and management of its services. It operates through the following business segments: Digital Data Solutions (DDS), Synodex, and Agility. The DDS segment combines deep neural networks and human expertise in multiple domains to make unstructured information useable. The Synodex segment enables clients in the insurance and healthcare sectors to transform medical records into useable digital data and to apply technologies to the digital data to augment decision support. The Agility segment provides tools and related professional services that enable public relations and communications professionals to discover influencers, amplify messages, monitor coverage, and measure the impact of campaigns. The company was founded by Todd H. Solomon in 1988 and is headquartered in Ridgefield Park, NJ.

Innodata Inc

Innodata is trending due to its new partnership with Palantir for AI data engineering, with the community largely interpreting this as a critical entry point into government and military contracts. Investors are keenly anticipating upcoming earnings to validate this momentum, while actively debating the stock's high volatility and potential for a significant short squeeze.

America's Oil Reserve for the Digital Age

U.S Oil

USOR CRYPTO is trending amidst feverish speculation, driven by recent sharp gains and high anticipation for a 'huge announcement' or 'February 1st' event that has many envisioning significant price increases. This intense bullish sentiment is sharply contrasted by a large segment of the community warning of a potential scam or rug pull, fueling a deeply divided and cautionary discussion around the token's legitimacy.

Hedera is a decentralized public network where developers can build secure, fair applications with near real-time consensus. The platform is owned and governed by a council of global innovators including Avery Dennison, Boeing, Deutsche Telekom, DLA Piper, FIS (WorldPay), Google, IBM, LG Electronics, Magalu, Nomura, Swirlds, Tata Communications, University College London (UCL), Wipro, and Zain Group.   The Hedera Consensus Service (HCS) acts as a trust layer for any application or permissioned network and allows for the creation of an immutable and verifiable log of messages. Application messages are submitted to the Hedera network for consensus, given a trusted timestamp, and fairly ordered. Use HCS to track assets across a supply chain, create auditable logs of events in an advertising platform, or even use it as a decentralized ordering service.

Hedera Hashgraph

Hedera (HBAR) is a trending topic as the crypto community anticipates progress on the Clarity Act and digests recent news of its World Economic Forum participation and McLaren partnership; however, discussions are polarized between those accumulating due to perceived utility and enterprise adoption, and frustrated investors lamenting continued price stagnation.

Ethereum is a global, open-source platform for decentralized applications. In other words, it is a decentralized blockchain platform that enables developers to build and deploy smart contracts and applications without central authority control. Unlike Bitcoin, which primarily functions as digital currency, Ethereum operates as a programmable global computer where developers can create any type of decentralized service.   The platform hosts over $14 billion in DeFi applications with hundreds of thousands of active users across financial protocols, NFT marketplaces, and gaming platforms. Its transition to Proof of Stake in September 2022 reduced energy consumption by over 99%, addressing environmental concerns while strengthening network security.  The network operates through thousands of independent validator nodes that process transactions and execute smart contracts on the Ethereum Virtual Machine. Smart contracts are self-executing programs written in Solidity that automatically carry out agreements when conditions are met, eliminating intermediaries like banks or brokers.   Validators stake ETH as collateral to propose and validate blocks, earning rewards for honest participation while facing penalties for malicious behavior. The EIP-1559 upgrade introduced a dynamic base fee mechanism that burns ETH with each transaction, creating deflationary pressure during high network activity when more ETH is burned than issued to validators.  Vitalik Buterin proposed Ethereum in 2013, but seven co-founders helped build it, including Gavin Wood who created Solidity and the EVM technical specification, and Joseph Lubin who founded ConsenSys. The project launched in July 2015 after raising over $18 million through crowdfunding, quickly becoming the largest blockchain developer community. Major milestones include the 2020 Beacon Chain launch, the 2021 London hard fork implementing fee burning, and the 2022 Merge to Proof of Stake.   Ether (ETH) serves multiple functions: paying transaction fees (gas), staking to secure the network and earn 3-5% annual yields, serving as collateral in DeFi protocols, and purchasing NFTs and digital assets. The asset is increasingly adopted by traditional institutions, with publicly traded companies adding ETH to corporate treasuries to generate staking yields while maintaining blockchain exposure, and in 2024, the SEC approved spot Ethereum ETFs, allowing traditional investors to gain exposure through conventional brokerage accounts.  Ethereum's roadmap focuses on dramatically increasing transaction capacity to over 100,000 per second, reducing confirmation times, and enhancing decentralization while maintaining security against future threats like quantum computing.

Ethereum

Ethereum is trending due to a significant market-wide sell-off and liquidations, which has fueled widespread bearish sentiment among some traders. However, others are actively discussing substantial institutional inflows into ETH ETFs, record staking activity, and new utility partnerships as indicators of underlying strength and a potential catalyst for recovery.

The White Whale

WhiteWhale Crypto is seeing a surge in community discussion following a major token burn and the locking of a significant portion of its supply until 2063, which supporters believe signals strong long-term potential. The cryptocurrency is also gaining attention as the community identifies and addresses alleged market manipulation, driving renewed interest and trading volume.

Bankr is an advanced AI agent focused on simplifying the process of buying and selling digital assets. Bankr was the first AI agent on Farcaster to help you quickly buy all your favorites coins directly in the social. BankrCoin is the official coin of the agent and was deployed by Bankr itself directly in the Farcaster social feed. Fees from swaps go to support BankrCoin. Bankr is available on Farcaster and will soon be launching a private terminal, token recs, and limit orders on Base.

BankrCoin

BankrCoin (BNKR) is trending amid discussions of its significant technological developments as an AI agent token on the Base network, driving a split in community sentiment between those anticipating parabolic growth and others cautioning about a pump-and-dump. Its rising volume and utility for AI-powered trades are fueling the debate, as it gains traction among holders while facing skepticism.

Coeptis Therapeutics Holdings, Inc. is a biopharmaceutical company, which engages in developing innovative cell therapy platforms for cancer that can disrupt conventional treatment paradigms and improve patient outcomes. It operates through the Biotechnology and Technology segments. The Biotechnology segment is involved in developing biotechnology product pipelines. The Technology segment relates to acquiring technology assets to support and enhance operational capabilities through advanced technologies. The company was founded in 2017 and is headquartered in Wexford, PA.

Coeptis Therapeutics Holdings Inc

Coeptis Therapeutics Inc

Coeptis Therapeutics is trending due to its imminent merger with Dogecoin and Litecoin miner Z Squared, marking a strategic pivot into altcoin mining and AI technology. The community anticipates the shareholder vote and final completion, with discussions focusing on the perceived undervaluation, potential for a short squeeze given the low float, and the company's future ties to cryptocurrency performance.

Peloton Interactive, Inc. provides an at-home fitness platform for live and on-demand indoor cycling classes. The firm pioneered connected, technology-enabled fitness, and the streaming of immersive, instructor-led boutique classes for its members. It operates through the Connected Fitness Products and Subscription segments. The Connected Fitness Products segment includes the sales of bikes, tread & related accessories. The Subscription segment refers to the monthly subscription and credits from live studio classes. The company was founded by John Foley, Graham Stanton, Thomas Cortese, Yony Feng, and Hisao Kushi in 2012 and is headquartered in New York, NY.

Peloton Interactive Inc - Ordinary Shares - Class A

Peloton Interactive Inc

Peloton is trending as it executes 11% staff cuts for cost savings, signaling a focus on profitability ahead of upcoming earnings, with community debate centered on whether new AI-powered products and turnaround efforts can counter sluggish sales and persistent market skepticism.

Global X Funds - Global X Silver Miners ETF

Global X Silver Miners ETF (SIL) is trending as spot silver experiences a parabolic surge to new highs, driven by persistent supply deficits and escalating industrial demand from sectors like AI and EVs. Despite recent underperformance relative to the metal, the community widely expects a significant catch-up rally in silver mining stocks as fundamental drivers continue to strengthen.

VanEck ETF Trust - VanEck Gold Miners ETF

VanEck Gold Miners ETF

GDX is heavily trending as gold and silver prices soar to new highs, fueled by escalating global geopolitical tensions and a growing lack of trust in fiat currencies among institutions and central banks. The community is actively discussing how relentless US money printing and massive deficits are driving a historic shift into hard assets, with many believing gold miners remain significantly undervalued and poised for further upside in this parabolic market environment.

statis crypto Watchlist

Bitcoin

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

AlphaQuest LLC Acquires 34,011 Shares of Halozyme Therapeutics, Inc. $HALO

AlphaQuest LLC grew its holdings in Halozyme Therapeutics, Inc. (NASDAQ:HALO - Free Report) by 640.7% in the third quarter, according to the company in its most recent Form 13F filing with the SEC...

Halozyme Therapeutics (NASDAQ:HALO) Raised to Strong-Buy at Wall Street Zen

Wall Street Zen upgraded shares of Halozyme Therapeutics from a "buy" rating to a "strong-buy" rating in a research note on Saturday...

Why Halozyme Therapeutics (HALO) is a Top Momentum Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

If You Invested $1000 in Halozyme Therapeutics a Decade Ago, This is How Much It'd Be Worth Now

Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.

Q4 EPS Forecast for Halozyme Therapeutics Lifted by Analyst

Halozyme Therapeutics, Inc. (NASDAQ:HALO - Free Report) - Stock analysts at Zacks Research increased their Q4 2025 earnings per share estimates for shares of Halozyme Therapeutics in a report issued...

Great Lakes Advisors LLC Sells 14,747 Shares of Halozyme Therapeutics, Inc. $HALO

Great Lakes Advisors LLC lessened its holdings in Halozyme Therapeutics, Inc. (NASDAQ:HALO - Free Report) by 10.9% during the third quarter, according to its most recent 13F filing with the...

HALO Rises Nearly 4% on Strong 2025 Preliminary Data and 2026 Guidance

Halozyme Therapeutics' shares jump nearly 4% after preliminary 2025 results beat expectations and management lifts 2026 outlook.

Halozyme Therapeutics (NASDAQ:HALO) Updates FY 2026 Earnings Guidance

Halozyme Therapeutics (NASDAQ:HALO) updated its FY 2026 earnings guidance. The company provided EPS guidance of 7.750-8.250 for the period, compared to the consensus estimate of 7.860. The company...

Federated Hermes Inc. Has $106.40 Million Stock Holdings in Halozyme Therapeutics, Inc. $HALO

Federated Hermes Inc. raised its stake in Halozyme Therapeutics, Inc. (NASDAQ:HALO - Free Report) by 294.1% in the third quarter, according to the company in its most recent disclosure with the...

<ul class="summary-bullets"><li>Halozyme Therapeutics also raised its 2026 revenue guidance to $1.71 - $1.81 billion, representing growth of 23% to 30%, higher than an analyst estimate of $1.69 billion.</li><li>The company now expects adjusted earnings per share of $7.75 - $8.25 for 2026, up from its previous estimate of $6.50 to $7.00.</li><li>Halozyme on Wednesday also said that it acquired Surf Bio for up to $400 million in December to expand its drug delivery opportunity.</li></ul>Shares of Halozyme Therapeutics, Inc. (HALO) rallied 3% on Wednesday after the company announced preliminary 2025 estimates above Wall Street expectations. The company also announced the acquisition of Surf Bio.The biopharmaceutical company <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://ir.halozyme.com/news/news-details/2026/Halozyme-Raises-2025-Revenue-Estimates-Raises-2026-and-Multi-Year-Financial-Guidance/default.aspx">said</a> that it now expects 2025 total revenue of $1.385 - $1.4 billion, representing a year-on-year growth of 36% to 38%, and exceeding a Wall Street estimate of $1.34 billion.<h2 class="st-heading-2">Year Ahead</h2>The company also raised its 2026 revenue guidance to $1.71 - $1.81 billion, representing growth of 23% to 30%, higher than an analyst estimate of $1.69 billion, backing on a sharp increase in royalty revenue. The company had previously predicted 2026 revenue in the range of $1.43 to $1.53 billion.The company now expects adjusted earnings per share of $7.75 - $8.25 for 2026, up from its previous estimate of $6.50 to $7.00, and in line with an analyst estimate of $8.21.&nbsp;&nbsp;&nbsp;&nbsp;"Our increased multi-year guidance reflects both the strength of our core ENHANZE (drug delivery technology) business and the exceptional momentum we built in 2025,” CEO Helen Torley said.“By the end of 2026, we project we will have 15 partner programs in development and have signed three or more new drug delivery licensing agreements, expanding the reach and growing our opportunity through our diversified drug delivery portfolio,” Torley added.<h2 class="st-heading-2">Surf Bio Acquisition</h2>Halozyme on Wednesday also said that it acquired pharmaceutical firm Surf Bio for up to $400 million in December to expand its drug delivery opportunity.The deal included an upfront payment of $300 million and milestone payments of up to $100 million.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around HALO stock rose from ‘bearish’ to ‘bullish’ territory over the past 24 hours, while message volume increased from ‘normal’ to ‘high’ levels.A Stocktwits user voiced confidence in the company’s new CEO Helen Torley attracting a broader range of investors.<stembedurl>https://www.stocktwits.com/Sean29md/message/643129433</stembedurl><a href="https://stocktwits.com/symbol/HALO">HALO stock</a> has risen 29% over the past 12 months.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/why-is-feed-stock-soaring-over-150-percent/cmygQhUR40m">Why Is FEED Stock Soaring Over 130% Today?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Halozyme Therapeutics company logo is seen displayed on a smartphone screen. (Photo Illustration by Piotr Swat/SOPA Images/LightRocket via Getty Images)

HALO Stock Edges Up 3% On Upbeat Multi-Year Revenue Guidance, Surf Bio Acquisition

The biopharmaceutical company said that it now expects 2025 total revenue of $1.385 - $1.4 billion, representing a year-on-year growth of up to 38%.

Equity

The biopharmaceutical company said that it now expects 2025 total revenue of $1.385 - $1.4 billion, representing a year-on-year growth of up to 38%.


Halozyme Therapeutics, Inc. is a biopharmaceutical technology platform company. It engages in developing, manufacturing, and commercializing drug-device combination products using advanced auto-injector technology that are designed to provide commercial or functional advantages such as improved convenience and tolerability, and enhanced patient comfort and adherence. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA.

HALO
Halozyme Therapeutics Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest HALO News

HALOHalozyme Therapeutics Inc.